Exeter Handkerchief Factory hits market at $3.5M
A vestige of Exeter’s industrial past in the historic Lincoln Street corridor is up for sale, and it has a hefty price tag.
Sections
Extras
Connect With Us

Construction has begun on Cobblestone Pointe Senior Village, a $16 million, 110-unit senior housing development at near the Steeplegate Mall in Concord.
The independent living complex is being built by Wheatfield, N.Y.-based Calamar, which also owns Maple Ridge Estates in Bedford, which is set to open in 2017, and The Grand Estate at Londonderry, set to open in 2016.
Cobblestone Pointe is expected to open in the summer of 2017.
The one- and two-bedroom apartments would be available to tenants older than 62. Rents for the one- and two-bedroom apartments are expected to range from $1,043 to $1,290 per month.
A vestige of Exeter’s industrial past in the historic Lincoln Street corridor is up for sale, and it has a hefty price tag.
Real estate transactions in New Hampshire invariably carry tax consequences. Whether you are a business owner, investor, or advisor, thoughtful tax planning is critical to preserving value and avoiding costly missteps.
Since 2020, our research team at the University of New Hampshire — the New Hampshire Youth Retention Initiative (YRI) — has been studying how young people view the Granite State as a place to live, learn and work.
The people of New Hampshire are facing unprecedented economic challenges — no one has been spared from rising grocery bills, increased rent and utility costs, and even higher car insurance premiums.
When I started my first business in 1982, I didn’t know exactly where the journey would lead. What I did know was that I wanted to build something lasting, something rooted in innovation and capable of creating good jobs.
Business and event happenings around the state of NH
The Latest is a roundup of the comings and goings of the movers and shakers in NH's business community
Reform bill cosponsored by U.S. Sen. Maggie Hassan would break the link between PBM compensation and drug prices